IMMUNOPRECISE ANTIBODIES LTD (IPA)
Institutional ownership reported to the SEC as of Q3 2025, across 20 quarters.
1
Reporting holders
$17.5K
Reported value
0.0%
Held as options
-22
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $17.5K | 10,000 | 0.00% | 3q | -50.0%-$17.5K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | $17.5K | 10,000 | 0 | 0 | 1 | 0.0% |
| Q2 2025 | 23 | $1.4M | 1,186,118 | 5 | 5 | 4 | 11.0% |
| Q1 2025 | 21 | $423.1K | 1,061,689 | 7 | 1 | 4 | 5.5% |
| Q4 2024 | 15 | $116.8K | 283,698 | 0 | 2 | 3 | 0.0% |
| Q3 2024 | 16 | $190.1K | 297,014 | 1 | 4 | 3 | 0.0% |
| Q2 2024 | 17 | $351.3K | 311,986 | 1 | 4 | 3 | 8.9% |
| Q1 2024 | 21 | $614.5K | 325,304 | 4 | 4 | 3 | 19.2% |
| Q4 2023 | 22 | $1.3M | 408,972 | 6 | 5 | 2 | 46.1% |
| Q3 2023 | 16 | $1.3M | 292,226 | 2 | 1 | 5 | 51.1% |
| Q2 2023 | 16 | $2.4M | 381,116 | 1 | 1 | 7 | 50.4% |
| Q1 2023 | 18 | $2.9M | 574,302 | 2 | 3 | 4 | 42.3% |
| Q4 2022 | 17 | $6.4M | 460,657 | 4 | 3 | 4 | 62.3% |
| Q3 2022 | 20 | $8.8M | 1,518,155 | 1 | 7 | 2 | 31.4% |
| Q2 2022 | 23 | $8.8M | 1,465,947 | 3 | 4 | 6 | 36.1% |
| Q1 2022 | 23 | $11.3M | 1,383,600 | 3 | 5 | 6 | 37.0% |
| Q4 2021 | 26 | $12.1M | 1,436,172 | 1 | 8 | 8 | 29.6% |
| Q3 2021 | 28 | $12.6M | 1,349,257 | 13 | 9 | 3 | 27.8% |
| Q2 2021 | 25 | $10.2M | 1,475,262 | 9 | 8 | 5 | 4.6% |
| Q1 2021 | 19 | $13.7M | 1,395,860 | 8 | 9 | 1 | 0.0% |
| Q4 2020 | 14 | $8.1M | 541,383 | 14 | 0 | 0 | 0.0% |